Literature DB >> 8033360

Interleukin-6 an endocrine cytokine.

T H Jones1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033360     DOI: 10.1111/j.1365-2265.1994.tb02502.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  9 in total

1.  Mechanisms and significance of the increased brain uptake of tryptophan.

Authors:  Natalie R Lenard; Adrian J Dunn
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  Cloning and characterization of the type I inositol 1,4,5-trisphosphate receptor gene promoter. Regulation by 17beta-estradiol in osteoblasts.

Authors:  K L Kirkwood; K Homick; M B Dragon; P G Bradford
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

3.  The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs.

Authors:  H S Moeniralam; W A Bemelman; E Endert; R Koopmans; H P Sauerwein; J A Romijn
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 4.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

5.  Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands.

Authors:  George Kontogeorgos; Irene Messini; Efi Kyrodimou; Linda Giannikaki; Emmanuel Zois; George Koukoulis; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.633

Review 6.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

7.  A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Authors:  Seema Kumar; Reagan Schiefer; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

8.  Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Authors:  R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

9.  Primary thyroid disorders in patients with endogenous hypercortisolism: an observational study.

Authors:  Eda Demir Onal; Muhammed Sacikara; Fatma Saglam; Reyhan Ersoy; Bekir Cakir
Journal:  Int J Endocrinol       Date:  2014-05-05       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.